Listen: Live! From JPM 2024

s biotech back from its downturn? Can Nvidia solve biology? And is it wise to do a deal on a party bus? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Recording from the J.P. Morgan Healthcare Conference, we discuss how a spate of deals and some intermittent sunshine seem to have brightened the outlook for biotech at the outset of 2024.

We also talk about the latest twist in the Sarepta Therapeutics saga, a ubiquitous dealmaker, and life on the party circuit. For more on what we cover, here’s ; here’s ; here’s ; here’s ; here’s ; and here’s . Be sure to sign up on , , , , or wherever you get your podcasts. And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email ..